Open Access

Neuropilin-1 promotes primary liver cancer progression by potentiating the activity of hepatic stellate cells

  • Authors:
    • Zhi‑Chao Xu
    • Hao‑Xin Shen
    • Chen Chen
    • Li Ma
    • Wen‑Zhi Li
    • Lin Wang
    • Zhi‑Min Geng
  • View Affiliations

  • Published online on: December 7, 2017     https://doi.org/10.3892/ol.2017.7541
  • Pages: 2245-2251
  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

As a co‑receptor for a variety of cytokines, neuropilin‑1 (NRP‑1) is detectable in primary liver cancer (PLC) cells. Previous studies determined that silencing of NRP‑1 expression attenuated the proliferation, migration and invasion of PLC cells. An increasing number of studies have highlighted the crucial role of the tumor microenvironment in the pathogenesis of cancer. Hepatic stellate cells (HSCs) are one of the major interstitial cell types present in the liver tumor microenvironment, and can promote the proliferation, migration and invasion of PLC cells. It remains unknown whether NRP‑1 can promote PLC progression by potentiating the activity of HSCs. In the present study, the expression of NRP‑1, and its co‑expression with platelet‑derived growth factor receptor‑β, in HSCs was detected via immunofluorescence. LX2 HSCs were transfected with NRP‑1 short hairpin RNA lentiviral vectors and their proliferation was observed. The proliferation, migration and invasion of HepG2 cells co‑cultured with LX2 cells were also observed. Finally, LX2 and HepG2 cells were co‑injected into nude mice as subcutaneous xenografts, and the tumor growth and α‑smooth muscle actin expression levels were observed. NRP‑1 knockdown attenuated LX2 cell activation, with concomitant downregulation of HepG2 cell proliferation, migration and invasion (P<0.05). Thus, silencing of NRP‑1 expression may inhibit the activation of HSCs, as well as the proliferation, migration and invasion of PLC cells. The mechanism underlying the inhibition of PLC cell progression is possibly mediated by the inhibition of HSC activation, reduction of transforming growth factor‑β1 levels in the conditioned medium and downregulation of extracellular signal‑related kinase activity in PLC cells. Thus, NRP‑1 could be regarded as a potential gene therapy target for PLC.
View Figures
View References

Related Articles

Journal Cover

February-2018
Volume 15 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu ZC, Shen HX, Chen C, Ma L, Li WZ, Wang L and Geng ZM: Neuropilin-1 promotes primary liver cancer progression by potentiating the activity of hepatic stellate cells. Oncol Lett 15: 2245-2251, 2018.
APA
Xu, Z., Shen, H., Chen, C., Ma, L., Li, W., Wang, L., & Geng, Z. (2018). Neuropilin-1 promotes primary liver cancer progression by potentiating the activity of hepatic stellate cells. Oncology Letters, 15, 2245-2251. https://doi.org/10.3892/ol.2017.7541
MLA
Xu, Z., Shen, H., Chen, C., Ma, L., Li, W., Wang, L., Geng, Z."Neuropilin-1 promotes primary liver cancer progression by potentiating the activity of hepatic stellate cells". Oncology Letters 15.2 (2018): 2245-2251.
Chicago
Xu, Z., Shen, H., Chen, C., Ma, L., Li, W., Wang, L., Geng, Z."Neuropilin-1 promotes primary liver cancer progression by potentiating the activity of hepatic stellate cells". Oncology Letters 15, no. 2 (2018): 2245-2251. https://doi.org/10.3892/ol.2017.7541